High-Volume Scanners
PRODUCTS
-
Electronic informed consent for patient-centric decentralized clinical trials.
-
The MadAFM sample scanning atomic force microscope is powered by industry-leading closed-loop nanopositioners to ensure high-resolution performance, true decoupled motion, and virtually undetectable out-of-plane motion.
-
PHCbi brand's 5.0 cu.ft (142L) undercounter vaccine refrigerator is designed with a compact footprint for functional workspaces and fits under most tables, cabinets and lab benches. A convenient glass door provides visibility into the interior of the unit to avoid unnecessary door openings. If the door is left ajar, the self-closing mechanism mitigates scenarios that could result in lost product. An optional stacking accessory is available to maximize storage capacity when space constraints become a concern.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
-
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.
WHITE PAPERS AND CASE STUDIES
-
The True ROI Of Decentralized Clinical Trials
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Revolutionizing Biofilm Research: High-Resolution, Real-Time Imaging with ZeGage Optical Profiler
A university lab optimized biofilm research with Zygo’s ZeGage Optical Profiler, enabling high-resolution, real-time, non-contact imaging that accelerates data collection, enhances accuracy, and preserves biofilm integrity.
-
Boosting CMC Regulatory Efficiency In Gene Therapy
Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.
-
Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing
For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.
-
Why Choose Robotic Processing For Small Batch Aseptic Filling
Reducing human intervention in aseptic filling is critical for safety and cost efficiency. Learn why automation is essential for small-batch applications and how it’s transforming sterile drug manufacturing.
-
Simplifying The Transition To Multi-Column Chromatography
Explore the advantages of multi-column chromatography and how to transfer your process from batch to an intensified system, step-by-step.
-
Navigating Regulatory Compliance In Medical Device Development For Prefilled Syringes And Auto-Injectors
Developing prefilled syringes and auto-injectors requires rigorous mechanical, user-focused, and compliance testing to ensure device safety, effectiveness, and seamless regulatory approval for patient use.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
Scale Up Strategy For Oncolytic HSV-1 Vector Manufacturing
Discover how a novel, large-scale production method for herpes simplex virus type-1 vectors has the potential to accelerate the progress of gene therapy and bring it closer to widespread application.
-
Advancements In Microbial Manufacturing Of Biopharmaceuticals
Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.
-
Facility-Fit-Driven Process Development For A Monoclonal Antibody
See how proactively designing around plant constraints, using high-capacity resins, and leveraging parallel workstreams resulted in a 50% reduction in processing hours and 25% lower costs.
NEWS
-
Server Center Ltd. Launches EazeeSign For Secure Digital Transactions11/19/2025
Server Center Ltd. is proud to announce the official launch of EazeeSign, an innovative new platform for electronic signatures.
-
SmartVault Becomes First Document Management Platform To Integrate With Intuit ProConnect Tax1/28/2025
SmartVault, a leading provider of a cloud-based document management system (DMS) and client portal for accounting professionals, has expanded its ten-year strategic partnership with Intuit by integrating with ProConnect Tax, the industry-leading cloud-based tax software.
-
Experience Efficient And Flexible Scanning Solutions With Canon's New imageFORMULA R40II Office Document Scanner2/9/2026
Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the launch of the new imageFORMULA R40II Office Document Scanner.
-
pdfFiller By airSlate Introduces Renewed Word To PDF Feature To Enhance Document Management Efficiency2/7/2025
pdfFiller, a leading document management platform, has unveiled a renewed and improved version of its Word to PDF conversion feature.
-
Falcon Oil & Gas Ltd ('Falcon') - Another Stellar IP60 Flow Test Result In The Beetaloo And 2025 Drilling Campaign Commences7/14/2025
Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that Shenandoah S2-2H ST1 (“SS-2H ST1”) achieved an average 60-day initial production (“IP60”) flow rate of 6.8 million cubic feet per day (“MMcf/d”) over 1,671-metres (5,483-foot) across a 35 stage stimulated horizontal within the Amungee Member B-Shale in the Beetaloo Sub-basin, Northern Territory, Australia, making it the highest IP60 result in the Beetaloo to date.